Ansvarlig for undervisning i nefrologi.

Doktorgradsavhandling

• Sanjeevan Sriskandarajah; Rune Bjørneklett (2018). ANCA-associated glomerulonephritis. Prognostic factors and outcome in a Norwegian cohort. (ekstern lenke)
• Thomas Knoop; Rune Bjørneklett (2017). Prognostic aspects of IgA nephropathy. (ekstern lenke)
• Rune Bjørneklett (2012). Long-term prognosis in chronic primary glomerulonephritides. (ekstern lenke)

Fagartikkel

• Ingrid Viola Lavesson Thulin; Gard Mikael Saele Myrmel; Paul O Collinson et al. (2025). Diagnostic Accuracy of a Novel 0/1-H Algorithm Using Point-of-Care High-Sensitivity Troponin in the Emergency Department. (ekstern lenke)
• Ingrid Viola Lavesson Thulin; Silje Marie Farestveit Jordalen; Ole Christian Lekven et al. (2023). Aiming toWards Evidence baSed inTerpretation of Cardiac biOmarkers in patients pResenting with chest pain using Point of Care Testing (WESTCOR- POC): study design. (ekstern lenke)

Konferanseabstrakt

• Thomas Knoop; Bjørn Egil Vikse; Einar Svarstad et al. (2012). VALIDATION OF FRENCH MODEL TO PREDICT ESRD AND DEATH IN IGA NEPHROPATHY PATIENTS. (ekstern lenke)
• Thomas Knoop; Bjørn Egil Vikse; Einar Svarstad et al. (2012). STANDARDIZED MORTALITY RATE IN IGA NEPHROPATHY PATIENTS. (ekstern lenke)

Rettelse i tidsskrift

• Dagfinn Lunde Markussen; Øyvind Kommedal; Siri Tandberg Knoop et al. (2024). Corrigendum to “Microbial aetiology of community-acquired pneumonia in hospitalised adults: A prospective study utilising comprehensive molecular testing” [International Journal of Infectious Diseases 143 (2024) 107019]. (ekstern lenke)

Vitenskapelig artikkel

• Ingar Ziad Restan; Yong Yong Tew; Ole-Thomas Steiro et al. (2026). Exploring Sex-Specific High-Sensitivity Cardiac Troponin Thresholds for Rule-Out of Non-ST-Elevation Myocardial Infarction. (ekstern lenke)
• Gard Mikael Saele Myrmel; Ragnhild Merckoll Helseth; Ole-Thomas Steiro et al. (2026). Circulating Markers of Neutrophil Extracellular Traps for Long-Term Prognosis in Patients With Acute Chest Pain. (ekstern lenke)
• Iman Karaji; Ole-Thomas Steiro; Gard Mikael Saele Myrmel et al. (2025). Limited incremental value of growth differentiation factor 15 in the initial evaluation of low and intermediate risk acute chest pain patients. (ekstern lenke)
• Ingrid Viola Lavesson Thulin; Silje Jordalen; Gard Mikael Saele Myrmel et al. (2025). Effectiveness of Point-of-Care High-Sensitivity Troponin Testing in the Emergency Department: A Randomized Controlled Trial. (ekstern lenke)
• Nasir Saeed; Ingar Ziad Restan; Ole-Thomas Steiro et al. (2025). Analytical Error of Cardiac Troponin and Impact on the Performance of Accelerated Diagnostic Protocols in Patients with Acute Chest Pain. (ekstern lenke)
• Gard Mikael Saele Myrmel; Nasir Saeed; Ole-Thomas Steiro et al. (2025). Sex Differences in the Prognostic Value of Circulating Biomarkers in Patients Presenting With Acute Chest Pain. (ekstern lenke)
• Ingar Ziad Restan; Ole-Thomas Steiro; John W. Pickering et al. (2025). Clinical derivation and data simulated validation of rule-out and rule-in algorithms for the Siemens Atellica IM high-sensitivity cardiac troponin I assay. (ekstern lenke)
• Mariell Lossius Rivedal; Ole Petter Nordbø; Yngvar Lunde Haaskjold et al. (2025). Lifetime progression of IgA nephropathy: a retrospective cohort study with extended long-term follow-up. (ekstern lenke)
• Dagfinn Lunde Markussen; Øyvind Kommedal; Siri Tandberg Knoop et al. (2024). Microbial aetiology of community-acquired pneumonia in hospitalised adults: A prospective study utilising comprehensive molecular testing. (ekstern lenke)
• Dagfinn Lunde Markussen; Sondre Serigstad; Christian Ritz et al. (2024). Diagnostic Stewardship in Community-Acquired Pneumonia with Syndromic Molecular Testing: A Randomized Clinical Trial. (ekstern lenke)
• Nasir Saeed; Ole-Thomas Steiro; Jørund Langørgen et al. (2024). Diagnosing Myocardial Injury in an Acute Chest Pain Cohort; Long-Term Prognostic Implications of Cardiac Troponin T and i. (ekstern lenke)
• Umael Khan; Anders Aarebrot; Solveig Mo Salbu et al. (2024). Epstein-Barr in a Patient Presenting with Right Upper Quadrant Pain: A Case Report from the Emergency Department. (ekstern lenke)
• Mariell Lossius Rivedal; Yngvar Lunde Haaskjold; Øystein Solberg Eikrem et al. (2024). Use of corticosteroids in Norwegian patients with immunoglobulin a nephropathy progressing to end-stage kidney disease: a retrospective cohort study. (ekstern lenke)
• Dagfinn Lunde Markussen; Jannicke Slettli Wathne; Christian Ritz et al. (2024). Determinants of non-adherence to antibiotic treatment guidelines in hospitalized adults with suspected community-acquired pneumonia: a prospective study. (ekstern lenke)
• Mariell Lossius Rivedal; Håvard Mikkelsen; Hans Peter Marti et al. (2023). Glomerular transcriptomics predicts long term outcome and identifies therapeutic strategies for patients with assumed benign IgA nephropathy. (ekstern lenke)
• Gard Mikael Saele Myrmel; Ole-Thomas Steiro; Hilde Lunde Tjora et al. (2023). Growth Differentiation Factor 15: A Prognostic Marker in Patients with Acute Chest Pain without Acute Myocardial Infarction. (ekstern lenke)
• Dagfinn Lunde Markussen; Heidi Synnøve Brevik; Rune Oskar Bjørneklett et al. (2023). Validation of a modified South African triage scale in a high-resource setting: a retrospective cohort study. (ekstern lenke)
• Dagfinn Lunde Markussen; Marit Helen Ebbesen; Sondre Serigstad et al. (2023). The diagnostic utility of microscopic quality assessment of sputum samples in the era of rapid syndromic PCR testing. (ekstern lenke)
• Sondre Serigstad; Siri Tandberg Knoop; Dagfinn Lunde Markussen et al. (2023). Diagnostic utility of oropharyngeal swabs as an alternative to lower respiratory tract samples for PCR-based syndromic testing in patients with community-acquired pneumonia. (ekstern lenke)
• Yngvar Lunde Haaskjold; Njål Lura; Rune Oskar Bjørneklett et al. (2023). Long-term follow-up of IgA nephropathy: clinicopathological features and predictors of outcomes. (ekstern lenke)
• Gard Mikael Saele Myrmel; Ole-Thomas Steiro; Hilde Lunde Tjora et al. (2023). Prognostic value of growth differentiation factor-15 3 months after an acute chest pain admission. (ekstern lenke)
• Ole-Thomas Steiro; Jørund Langørgen; Hilde Lunde Tjora et al. (2023). Prognostic significance of chronic myocardial injury diagnosed by three different cardiac troponin assays in patients admitted with suspected acute coronary syndrome. (ekstern lenke)
• DAGFINN LUNDE MARKUSSEN; Harleen Grewal; Siri Tandberg Knoop et al. (2022). Comparison of rapid molecular testing methods for detecting respiratory viruses in emergency care: a prospective study. (ekstern lenke)
• Sondre Serigstad; Dagfinn Lunde Markussen; Christian Ritz et al. (2022). The changing spectrum of microbial aetiology of respiratory tract infections in hospitalized patients before and during the COVID-19 pandemic. (ekstern lenke)
• Ole-Thomas Steiro; Kristin Moberg Aakre; Hilde Lunde Tjora et al. (2022). Association between symptoms and risk of non-ST segment elevation myocardial infarction according to age and sex in patients admitted to the emergency department with suspected acute coronary syndrome: a single-centre retrospective cohort study. (ekstern lenke)
• Nasir Saeed; Tone Merete Norekvål; Ole-Thomas Steiro et al. (2022). Predictors of long-term symptom burden and quality of life in patients hospitalised with chest pain: a prospective observational study. (ekstern lenke)
• Yngvar Lunde Haaskjold; Njål Gjærde Lura; Rune Oskar Bjørneklett et al. (2022). Validation of two IgA nephropathy risk-prediction tools using a cohort with a long follow-up. (ekstern lenke)
• Ingar Ziad Restan; Ana Yufera Sanchez; Ole-Thomas Steiro et al. (2022). Adding stress biomarkers to high-sensitivity cardiac troponin for rapid non-ST-elevation myocardial infarction rule-out protocols. (ekstern lenke)
• Sondre Serigstad; Christian Ritz; Daniel Faurholt-Jepsen et al. (2022). Impact of rapid molecular testing on diagnosis, treatment and management of community-acquired pneumonia in Norway: a pragmatic randomised controlled trial (CAPNOR). (ekstern lenke)
• Sondre Serigstad; Dagfinn Lunde Markussen; Harleen Grewal et al. (2022). Rapid syndromic PCR testing in patients with respiratory tract infections reduces time to results and improves microbial yield. (ekstern lenke)
• Heidi Synnøve Brevik; Karl Ove Hufthammer; Merete Eide Hernes et al. (2022). Implementing a new emergency medical triage tool in one health region in Norway: some lessons learned. (ekstern lenke)
• Yngvar Lunde Haaskjold; Rune Oskar Bjørneklett; Leif Bostad et al. (2022). Utilizing the MEST score for prognostic staging in IgA nephropathy. (ekstern lenke)
• Ole-Thomas Steiro; Hilde Lunde Tjora; Jørund Langørgen et al. (2021). Clinical risk scores identify more patients at risk for cardiovascular events within 30 days as compared to standard ACS risk criteria: The WESTCOR study. (ekstern lenke)
• Hilde Lunde Tjora; Ole-Thomas Steiro; Jørund Langørgen et al. (2021). Diagnostic performance of novel troponin algorithms for the rule-out of non-ST-elevation acute coronary syndrome. (ekstern lenke)
• Marius Altern Øvrehus; Tine Simensen Oldereid; Aydin Dadfar et al. (2020). Clinical phenotypes and long-term prognosis in white patients with biopsy-verified hypertensive nephrosclerosis. (ekstern lenke)
• Hilde Lunde Tjora; Ole-Thomas Steiro; Jørund Langørgen et al. (2020). Cardiac Troponin Assays With Improved Analytical Quality: A Trade‐Off Between Enhanced Diagnostic Performance and Reduced Long‐Term Prognostic Value. (ekstern lenke)
• Stein Hallan; Marius Altern Øvrehus; Rune Bjørneklett et al. (2020). Hypertensive nephrosclerosis: wider kidney biopsy indications may be needed to improve diagnostics. (ekstern lenke)
• Maria Weiner; Rune Bjørneklett; Zdenka Hrušková et al. (2019). Proteinase-3 and myeloperoxidase serotype in relation to demographic factors and geographic distribution in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. (ekstern lenke)
• Hilde Lunde Tjora; Ole-Thomas Steiro; Jørund Langørgen et al. (2019). Aiming toWards Evidence baSed inTerpretation of Cardiac biOmarkers in patients pResenting with chest pain-the WESTCOR study: study design. (ekstern lenke)
• Rune Bjørneklett; Leif Bostad; Anne-Siri Fismen (2018). Prognosis and Histological Classification in Elderly Patients with ANCA-Glomerulonephritis: A Registry-Based Cohort Study. (ekstern lenke)
• Rune Bjørneklett; Vilde Solbakken; Leif Bostad et al. (2018). Exploring sex-specific differences in the presentation and outcomes of ANCA-associated vasculitis: a nationwide registry-based cohort study. (ekstern lenke)
• Vilde Solbakken; Anne-Siri Fismen; Leif Bostad et al. (2018). Impact of proteinase 3 versus myeloperoxidase positivity on risk of end-stage renal disease in ANCA-associated glomerulonephritis stratified by histological classification: A population-based cohort study. (ekstern lenke)
• Rune Bjørneklett; Vilde Solbakken; Leif Bostad et al. (2018). Prognostic factors in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis with severe glomerular sclerosis: a national registry-based cohort study. (ekstern lenke)
• Gudrun Norby; Geir Mjøen; Rune Bjørneklett et al. (2017). Outcome in biopsy-proven Lupus nephritis: Evaluation of biopsies from the Norwegian Kidney Biopsy Registry. (ekstern lenke)
• Thomas Knoop; Bjørn Egil Vikse; Angela Mwakimonga et al. (2017). Long-term outcome in 145 patients with assumed benign immunoglobulin A nephropathy. (ekstern lenke)
• Sanjeevan Sriskandarajah; Leif Bostad; Tor Åge Myklebust et al. (2017). Cancer in ANCA-associated glomerulonephritis: a registry-based cohort study. (ekstern lenke)
• Francesco Pesce; Mattea Diciolla; Giulio Binetti et al. (2016). Clinical decision support system for end-stage kidney disease risk estimation in IgA nephropathy patients. (ekstern lenke)
• Rune Bjørneklett; Sanjeevan Sriskandarajah; Leif Bostad (2016). Prognostic value of histologic classification of ANCA-associated glomerulonephritis. (ekstern lenke)
• Mattea Diciolla; Giulio Binetti; Tommaso Di Noia et al. (2015). Patient classification and outcome prediction in IgA nephropathy. (ekstern lenke)
• Thomas Knoop; Ann Merethe Vågane; Bjørn Egil Vikse et al. (2015). Addition of eGFR and age improves the prognostic absolute renal risk-model in 1,134 norwegian patients with IgA nephropathy. (ekstern lenke)
• Sanjeevan Sriskandarajah; Knut Aasarød; Steinar Skrede et al. (2014). Improved prognosis in Norwegian patients with glomerulonephritis associated with anti-neutrophil cytoplasmic antibodies. (ekstern lenke)
• Thomas Knoop; Bjørn Egil Vikse; Einar Svarstad et al. (2013). Mortality in patients with IgA nephropathy. (ekstern lenke)
• Rune Bjørneklett; Bjørn Egil Vikse; Leif Bostad et al. (2012). Long-term risk of ESRD in IgAN; validation of Japanese prognostic model in a Norwegian cohort. (ekstern lenke)
• Rune Bjørneklett; Bjørn Egil Vikse; Hilde Kloster Smerud et al. (2011). Pre-transplant course and risk of kidney transplant failure in IgA nephropathy patients. (ekstern lenke)
• Karsten Midtvedt; Jan Bitter; Christina Dørje et al. (2009). Belatacept as Immunosuppression in Patient With Recurrence of Hemolytic Uremic Syndrome After Renal Transplantation. (ekstern lenke)
• Rune Oskar Bjørneklett; Bjørn Egil Vikse; Einar Svarstad et al. (2007). Long-term risk of cancer in membranous nephropathy patients. (ekstern lenke)

Se en fullstendig oversikt over publikasjoner i NVA.

Norsk Nyrebiopsiregister